Vertex Pharmaceuticals Stock Price

1.81 (0.79%)
Upgrade to Real-Time
Regular Market
Volume 486,354
Bid Price 230.35
Ask Price 230.45
News -
Day High 231.105


52 Week Range


Day Low 227.26
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.81 0.79% 230.42 10:59:47
Open Price Low Price High Price Close Price Prev Close
228.13 227.26 231.105 228.61
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,454 486,354 $ 229.43 $ 111,581,966 - 176.36 - 242.99
Last Trade Time Type Quantity Stock Price Currency
10:59:47 10 $ 230.43 USD


Draw Mode:

Vertex Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 58.58B 254.25M 254.11M $ 6.21B $ 1.77B 10.31 27.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -463.00 0.90%

more financials information »

Vertex Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week227.00234.58226.58231.221,964,1433.421.51%
1 Month222.66234.58214.66225.421,564,0757.763.49%
3 Months181.93234.58179.96204.991,942,49148.4926.65%
6 Months196.97234.58176.36197.991,799,09133.4516.98%
1 Year237.06242.99176.36203.901,955,947-6.64-2.8%
3 Years193.48306.08163.681215.691,651,80236.9419.09%
5 Years81.09306.0880.06189.641,621,641149.33184.15%

Vertex Pharmaceuticals Description

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Your Recent History
Vertex Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.